IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 189 filers reported holding IMMUNOGEN INC in Q3 2019. The put-call ratio across all filers is 0.21 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $441,932 | -76.7% | 27,847 | -72.3% | 0.00% | -80.0% |
| Q2 2023 | $1,897,680 | +2008.5% | 100,566 | +432.1% | 0.01% | – |
| Q1 2022 | $90,000 | -85.3% | 18,900 | -77.1% | 0.00% | -100.0% |
| Q4 2021 | $612,000 | +292.3% | 82,485 | +170.0% | 0.00% | +100.0% |
| Q4 2019 | $156,000 | -38.1% | 30,553 | -70.7% | 0.00% | -50.0% |
| Q3 2019 | $252,000 | +327.1% | 104,167 | +286.1% | 0.00% | +100.0% |
| Q2 2019 | $59,000 | -3.3% | 26,979 | +111.6% | 0.00% | – |
| Q4 2018 | $61,000 | +335.7% | 12,750 | +750.0% | 0.00% | – |
| Q3 2018 | $14,000 | -96.6% | 1,500 | -96.2% | 0.00% | -100.0% |
| Q1 2018 | $412,000 | +858.1% | 39,200 | +256.4% | 0.00% | – |
| Q1 2017 | $43,000 | -74.3% | 11,000 | -86.6% | 0.00% | -100.0% |
| Q4 2016 | $167,000 | +5466.7% | 82,000 | +6207.7% | 0.00% | – |
| Q3 2016 | $3,000 | -97.9% | 1,300 | -87.7% | 0.00% | -100.0% |
| Q4 2015 | $143,000 | +2760.0% | 10,558 | +2011.6% | 0.00% | – |
| Q3 2015 | $5,000 | +66.7% | 500 | +150.0% | 0.00% | – |
| Q2 2015 | $3,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 3,984,734 | $15,421,000 | 1.00% |
| Moloney Securities Asset Management, LLC | 274,450 | $1,062,000 | 0.55% |
| Schonfeld Strategic Advisors LLC | 1,025,176 | $3,968,000 | 0.40% |
| Orbimed Advisors | 6,095,647 | $23,590,000 | 0.27% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 113,216 | $438,000 | 0.26% |
| PINNACLE ASSOCIATES LTD | 1,589,959 | $6,153,000 | 0.12% |
| Baker Brothers Advisors | 3,015,353 | $11,669,000 | 0.10% |
| BAXTER BROS INC | 58,000 | $224,000 | 0.07% |
| SIMON QUICK ADVISORS, LLC | 25,000 | $97,000 | 0.06% |
| ClearBridge Investments | 14,428,856 | $55,840,000 | 0.06% |